Form 4 Accendra Health Inc For: 24 September
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Accendra Health Inc (ACH)
The Accendra Health share price today is 0.51, view NYSE ACH stock exchange data. Track the latest Accendra Health share price with real-time updates on ACH stock performance including market cap, day range, 52-week range and dividend yield. Access ACH charts, earnings dates and analyst estimates to support your investment decisions.
0.51
-0.04(-7.87%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.51
0.57
52 wk Range
0.51
5.60
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.510.57
52 wk Range
0.515.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ACH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
1.51
Upside
+196.57%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Management has been aggressively buying back shares
- Form 4 Accendra Health Inc For: 24 September
- Investing.com
Form 8K Accendra Health Inc For: 17 August- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Analyst Ratings
0 Buy
3 Hold
2 Sell
Ratings:
5 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 1.51
(+196.57% Upside)
Accendra Health Inc SWOT Analysis
Strategic Expansion | Explore Owens & Minor's $1.36 billion acquisition of Rotech, aimed at strengthening its position in the high-growth Patient Direct business |
Financial Challenges | Delve into the company's mixed Q3 results, revised guidance, and the implications of its recent CFO transition on financial stability |
Market Dynamics | Learn how Owens & Minor navigates industry shifts, including the impact of GLP-1 drugs and potential benefits from Chinese tariffs |
Analyst Perspectives | Discover varied analyst views on OMI's future, with price targets ranging from $14 to $23, reflecting both optimism and caution |
Accendra Health Inc Earnings Call Summary for Q2/2026
- Accendra Health slashed 2026 guidance to $2.45B-$2.55B revenue and $300M-$320M adjusted EBITDA; shares plunged 34% to $1.86 in premarket.
- Q2 adjusted EBITDA hit $60.1M, with collections delays from intense payer audits reducing revenue and EBITDA by approximately $10M in the quarter.
- Sleep revenue grew 5.5% and diabetes 4% YoY, but respiratory, wound care, and CGM categories remained weak; overall growth just 2% ex-payer impact.
- Company expects Q4 to strengthen significantly, targeting normalized $100M annual free cash flow in 2027 after new partnerships launch and costs stabilize.
- CEO Ed Pesicka plans to retire by end-2026; firm reduced debt by $400M since March but faces cash flow pressure and ongoing payer audit challenges.
Last Updated: 10-08-2026, 06:28 pm
Read Full TranscriptEarnings
Latest Release
10-08-2026
EPS / Forecast
-0.19 / 0.12
Revenue / Forecast
613.2M / 632.21M
Compare ACH to Peers and Sector
Metrics to compare | ACH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | 17.1x | −0.4x | |
PEG Ratio | −0.01 | 0.01 | 0.00 | |
Price/Book | −0.1x | 2.7x | 2.6x | |
Price / LTM Sales | 0.0x | 0.7x | 3.0x | |
Upside (Analyst Target) | 170.1% | 59.3% | 56.4% | |
Fair Value Upside | Unlock | 30.9% | 7.9% | Unlock |
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Accendra Health (ACH) Share Price Today?
The Accendra Health share price today is 0.51.
What is the current Accendra Health (ACH) share price and day range?
As of 02-10-2026, the Accendra Health share price is 0.51, with a previous close of 0.56. The share price has ranged from 0.51 to 0.57 today, while the 52-week range spans from 0.51 to 5.60.
What Is the Accendra Health Market Cap?
As of today, Accendra Health market cap is 39.22M.
What Is the Accendra Health (ACH) Share Price Target?
The average 12-month share price target for Accendra Health is 1.51, with a high estimate of 1.75 and a low estimate of 1.3. 0 analysts recommend buying, while 2 suggest selling, with an overall rating of Neutral and +196.57% Upside potential.
What Is Accendra Health's Earnings Per Share (TTM)?
The Accendra Health EPS (TTM) is -1.45.
When Is the Next Accendra Health Earnings Date?
Accendra Health will release its next earnings report on 04-11-2026.
From a Technical Analysis Perspective, Is ACH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Accendra Health Trade On?
Accendra Health is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Accendra Health?
The stock symbol for Accendra Health is "ACH."
How Many Times Has Accendra Health Stock Split?
Accendra Health has split 4 times.
How Many Employees Does Accendra Health Have?
Accendra Health has 6500 employees.
What Is the ACH Premarket Price?
ACH's last pre-market stock price is 0.57. The pre-market share volume is 697.00, and the stock has changed by 0.01, or 2.21%.
What Is the ACH After Hours Price?
ACH's last after hours stock price is 0.55, the stock has changed by -0.01, or -1.45%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.